Parkman Healthcare Partners LLC Acquires New Position in CVS Health Corporation $CVS

Parkman Healthcare Partners LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 391,791 shares of the pharmacy operator’s stock, valued at approximately $40,531,000. CVS Health comprises approximately 4.1% of Parkman Healthcare Partners LLC’s investment portfolio, making the stock its 3rd largest position.

Other large investors have also recently modified their holdings of the company. Handelsbanken Fonder AB increased its holdings in shares of CVS Health by 83.6% during the second quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock worth $112,729,000 after buying an additional 496,124 shares in the last quarter. State Street Corp grew its position in CVS Health by 2.1% during the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares during the last quarter. Legal & General Group Plc grew its position in CVS Health by 0.3% during the 4th quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock worth $738,777,000 after acquiring an additional 31,249 shares during the last quarter. Deutsche Bank AG increased its holdings in CVS Health by 28.4% in the 4th quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock worth $370,333,000 after purchasing an additional 1,031,998 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. bought a new position in CVS Health in the second quarter valued at about $49,622,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on CVS shares. Royal Bank Of Canada upped their price objective on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Sanford C. Bernstein boosted their target price on shares of CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a report on Tuesday, May 12th. Cantor Fitzgerald upped their price target on shares of CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Finally, Piper Sandler restated an “overweight” rating and issued a $113.00 price objective on shares of CVS Health in a report on Monday, June 1st. Twenty-two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Stock Performance

NYSE:CVS opened at $94.06 on Tuesday. The company has a market capitalization of $120.31 billion, a PE ratio of 24.88, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a 50 day simple moving average of $101.88 and a two-hundred day simple moving average of $89.08. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter in the previous year, the company earned $1.81 EPS. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s dividend payout ratio is 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.